Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features - Duan, Ting; Xu, Mingxin; Zhang, Haibo; Wu, Shengchang; Wang, Haochu; Guo, Zhenying (Frontiers in Oncology, 2024)